查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000906

超音波刀市場：2026-2032年全球市場預測，依產品、方法、應用、最終用戶及通路分類

Ultrasonic Scalpels Market by Product, Mode, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年，超音波手術刀市場價值為45.1億美元，預計到2026年將成長至49.5億美元，複合年成長率為9.63%，到2032年將達到86億美元。

主要市場統計數據
基準年 2025 45.1億美元
預計年份：2026年 49.5億美元
預測年份 2032 86億美元
複合年成長率 (%) 9.63%

簡潔而有力地介紹了超音波刀在外科專科和臨床護理路徑中的戰略重要性。

超音波刀是一種能量器械，它徹底改變了現代外科手術中組織切割和止血的概念。由於其作用機制（透過切割器械傳遞機械振動），與傳統電外科刀相比，超音波刀能夠在更精確地切割組織的同時抑制熱量擴散，因此，越來越多的外科手術開始採用超音波刀。在臨床實踐中，外科醫師高度重視其可控凝血和最大限度減少對周圍組織損傷的特性，這些特性會影響手術全期結果，例如出血量、手術時間和術後即刻恢復。

找出正在重塑超音波手術刀市場的變革性變化，包括技術創新、手術應用和供應鏈現代化。

超音波刀領域正經歷多重變革，這些變革共同重塑著醫院、門診手術中心和臨床醫生選擇設備的優先順序。首先，技術進步改進了器械的人體工學設計、刀片形狀和能量控制演算法，拓展了臨床應用範圍，並增強了外科醫生在複雜解剖區域使用超音波器械的信心。同時，微創手術的趨勢推動了對兼具切割精度和可靠止血功能的器械的需求，從而提高了對器械性能和與腹腔鏡平台兼容性的標準。

評估 2025 年美國關稅對外科器械採購、臨床採購和全球供應韌性的累積影響。

美國2025年實施的關稅對外科器械的採購、製造以及整個臨床供應鏈產生了許多營運影響。其中最直接的影響之一體現在籌資策略上。醫院和經銷商重新審視了其供應商組合以降低成本風險，一些機構還探索了供應商多元化以及在條件允許的情況下將生產外包到附近地區。作為應對措施，製造商重新評估了零件採購流程，協商了替代供應協議，並在某些情況下調整了生產地點，以維持利潤率並按時交付。

深入了解關鍵細分市場，將臨床用例、產品變體、醫療保健環境、外科手術和分銷管道轉化為可操作的實施策略。

市場細分闡明了臨床需求、設備設計、醫療環境、手術技術和市場准入管道如何相互交織，共同塑造超音波刀的普及趨勢。基於應用領域，本市場研究涵蓋了一般外科、婦科、腫瘤科、整形外科和泌尿系統，這些領域涵蓋了設備有效性、組織類型考量以及與手術流程的整合至關重要的關鍵臨床情境。每個專科對設備的性能要求各不相同。例如，腫瘤科通常強調複雜切除術中的切緣保護和止血，而婦科和泌尿系統則更注重組織保護和術後快速恢復。

區域營運情報重點關注全球主要區域的需求推動要素、還款趨勢、監管環境和部署障礙。

受法規結構、報銷模式和醫療基礎設施成熟度差異的影響，區域趨勢對超音波刀的普及和商業化有顯著影響。在美洲，公立和私立醫療系統在臨床決策中常常面臨平衡循證療效和成本控制的壓力，這為能夠證明術前術後獲益顯著且服務模式高效的製造商創造了機會。在歐洲、中東和非洲，監管協調和多元化的支付方環境要求製造商制定靈活的打入市場策略，並建立強大的本地臨床夥伴關係關係，以應對採購慣例實踐的差異。

競爭和企業資料，概述主要企業。

超音波刀領域的競爭格局是產品創新、策略夥伴關係和實證定位三者相互融合的結果。主要企業透過在能量控制、器械人體工學以及相關耗材生態系統方面不斷改進來脫穎而出，所有這些改進都旨在減少術中操作的阻力。同時，與臨床中心和外科領導者的合作仍然是商業化的基礎，因為同行評審的研究和真實世界數據（REWED）能夠加速產品在更廣泛的臨床醫生群體中的應用。

為超音波刀市場的行業領導者提供實用建議，以加速推廣應用、最佳化供應鏈並協調臨床和商業策略。

產業領導者可以透過調整產品開發、臨床合作和供應鏈韌性，使其與不斷變化的醫療保健系統需求相契合，加速技術推廣並鞏固市場地位。應優先投資於產生臨床證據，以證明在圍手術全期療效、患者復健和營運效率方面取得顯著改善。此類證據應用於醫院委員會材料和與保險公司的磋商，從而減少技術推廣的障礙並支持採購核准。

本書詳細介紹了在初級和二級調查中使用的穩健調查方法調查方法、資料檢驗技術、專家諮詢和證據三角檢驗。

本報告採用的分析方法整合了多種資料收集和檢驗方法，旨在對醫療設備發展趨勢和相關人員進行嚴謹且可重複的評估。初步調查包括對相關專業的醫生、採購經理和臨床工程師進行結構化訪談，以直接了解醫療設備的性能、工作流程整合方面的挑戰以及採購標準。除訪談外，還諮詢了供應鏈和物流專家，以了解採購部門對關稅變化和區域貿易趨勢的應對措施。

將技術趨勢、監管壓力和臨床部署模式聯繫起來，為相關人員。

總之，綜合分析將技術能力、採購實際情況和臨床應用模式連結起來，為策略決策提供一致的基礎。超音波刀兼具外科創新性和操作實用性，具有獨特的優勢；也就是說，它們既能帶來可衡量的臨床益處，又需要與醫院的工作流程、消毒通訊協定和採購優先事項緊密配合。因此，成功部署取決於能夠提供可靠的臨床證據、全面的培訓計劃和可預測的性能的供應鏈結構。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章超音波刀市場：依產品分類

  • Cavitron超音波吸引器
  • 超音波刀

第9章超音波刀市場依手術方法分類

  • 腹腔鏡手術
  • 開放性手術

第10章超音波刀市場：依應用領域分類

  • 一般外科
  • 婦科
  • 腫瘤學
  • 整形外科
  • 泌尿系統

第11章：超音波刀市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章：超音波刀市場：依分銷管道分類

  • 直銷
  • 銷售代理

第13章：超音波刀市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：超音波刀市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：超音波刀市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國超音波刀市場

第17章：中國超音波刀市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Axon Medical Solutions
  • Bioventus Inc.
  • BOWA-Electronic GmbH & Co. KG
  • Cadence Inc.
  • Duomed Belgium
  • Elite Medical
  • Hangzhou Rex Medical Instrument Co., Ltd.
  • Heal Force Bio-Meditech Holdings Limited
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LISI Group
  • Lotus Surgicals Pvt. Ltd.
  • Medtronic PLC
  • Olympus Corporation
  • Rivolution GmbH
  • SHANGHAI LZQ PRECISION TOOL CO., LTD
  • Shenzhen Jiayuanda Technology Co.,Ltd.
  • Sonics & Materials, Inc.
  • Stryker Corporation
  • Surgnova Healthcare Technologies
  • Soring GmbH
  • Wuhan BBT Mini-Invasive Medical Tech. Co., Ltd
Product Code: MRR-DD5AD9F59BCA

The Ultrasonic Scalpels Market was valued at USD 4.51 billion in 2025 and is projected to grow to USD 4.95 billion in 2026, with a CAGR of 9.63%, reaching USD 8.60 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.51 billion
Estimated Year [2026] USD 4.95 billion
Forecast Year [2032] USD 8.60 billion
CAGR (%) 9.63%

A concise, high-impact introduction framing the strategic importance of ultrasonic scalpels across surgical specialties and clinical care pathways

Ultrasonic scalpels represent a class of energy devices that have redefined tissue dissection and hemostasis across modern surgical practice. Their mechanism-mechanical vibration transmitted through a cutting instrument-delivers precise tissue transection with reduced thermal spread compared with traditional electrosurgery, and as a result they appear across a growing array of procedures. In clinical settings, surgeons value the combination of controlled coagulation and minimal collateral tissue damage, attributes that influence perioperative outcomes such as blood loss, operative time, and immediate postoperative recovery.

Beyond technical performance, adoption patterns reflect an interplay between clinical training, hospital procurement priorities, and procedure-specific value propositions. Consequently, decision-makers assess these devices not only on technical specifications but also on how they integrate into care pathways, instrumentation ecosystems, and sterilization workflows. As a transitional technology that interfaces closely with both open and minimally invasive techniques, ultrasonic scalpels occupy a strategic position in surgical modernization efforts where patient outcome improvements and operational efficiencies converge.

Taken together, these dynamics create a landscape in which clinical evidence, user ergonomics, and effective procurement strategies determine whether a device progresses from interesting innovation to routine standard of care. Therefore, a nuanced introduction to the technology must consider device characteristics, clinical preferences, and organizational readiness in equal measure.

Identifying transformative shifts reshaping the ultrasonic scalpel landscape including technology innovation, procedural adoption, and supply chain modernization

The ultrasonic scalpel landscape is undergoing multiple, concurrent shifts that collectively reframe how hospitals, ambulatory surgery centers, and clinicians prioritize device selection. First, technological advances have refined instrument ergonomics, blade geometries, and energy-control algorithms, which have expanded clinical indications and improved surgeon confidence in deploying ultrasonic devices in complex anatomical regions. At the same time, procedural trends toward minimally invasive approaches have driven demand for instruments that provide both cutting precision and consistent hemostasis, thereby raising the bar for device performance and compatibility with laparoscopic platforms.

In parallel, supply chain modernization and vendor consolidation influence procurement strategies. Health systems increasingly emphasize total cost of ownership, sterilization logistics, and interoperability with existing OR fleets, which changes negotiation dynamics and the criteria by which products compete. Moreover, regulatory and reimbursement contexts are evolving, prompting manufacturers to align clinical evidence generation with payer expectations and hospital formularies. Finally, clinician-led innovation and the emergence of hybrid workflows-where open and laparoscopic techniques co-exist-are pushing manufacturers to design devices that perform reliably across modes of surgery.

Collectively, these transformative shifts require stakeholders to reassess product development roadmaps, clinical trial designs, and commercial strategies so that innovation delivers measurable improvements in both clinical and operational outcomes.

Assessing the cumulative impact of United States tariffs in 2025 on device sourcing, clinical procurement, and global supply resilience for surgical instruments

The imposition of tariffs by the United States in 2025 introduced a series of operational consequences that ripple through procurement, manufacturing, and clinical supply chains for surgical instruments. One immediate effect concerns sourcing strategies: hospitals and distributors reassessed supplier portfolios to mitigate cost exposure, prompting some organizations to diversify vendors or to consider nearshoring where feasible. In turn, manufacturers reassessed component sourcing, negotiating alternative supply contracts and, in several cases, adjusting production footprints to preserve margin and maintain delivery timelines.

Consequently, procurement teams heightened scrutiny of landed costs and logistical lead times, and they increasingly required transparent supplier cost breakdowns and contingency plans. These changes accelerated conversations about strategic inventory buffers, multi-sourcing arrangements, and consignment models to reduce disruption risk. At the same time, clinical adoption decisions became more tightly linked to procurement economics; hospital committees asked surgical teams to justify device selection not only on clinical merits but also on supply reliability and predictable total cost of ownership.

Looking forward, tariff-driven pressures catalyzed more collaborative supplier-health system relationships focused on contractual flexibility, shared inventory visibility, and iterative product innovation that lowers dependence on tariff-sensitive components. In summary, the tariff environment of 2025 emphasized operational resilience and encouraged a reorientation of procurement and manufacturing practices toward robustness and transparency.

Key segmentation insights that translate clinical use cases, product variants, care settings, surgical modes, and distribution channels into actionable adoption strategies

Segmentation clarifies how clinical need, device design, care setting, surgical technique, and go-to-market channels intersect to shape adoption trajectories for ultrasonic scalpels. Based on Application, market is studied across General Surgery, Gynecology, Oncology, Orthopedics, and Urology, which captures the primary clinical contexts where device efficacy, tissue type considerations, and surgical workflow integration are most consequential. Each of these specialties demands distinct performance characteristics; for example, oncology often emphasizes margin preservation and hemostasis in complex resections, whereas gynecology and urology prioritize tissue-sparing techniques and rapid recovery.

Based on Product, market is studied across Cavitron Ultrasonic Surgical Aspirator and Harmonic Scalpel, reflecting differences in device architecture, energy delivery, and clinical indications that inform purchasing committees and surgeon preferences. These product distinctions translate into different training requirements, sterilization considerations, and consumable ecosystems. Based on End User, market is studied across Ambulatory Surgery Centers, Hospitals, and Specialty Clinics, which frames how scale, case mix, and purchasing authority influence procurement cycles and service models. Ambulatory centers may prioritize disposability and throughput, while hospitals balance capital investments with cross-department utilization.

Based on Mode, market is studied across Laparoscopic Surgery and Open Surgery, acknowledging that instrument compatibility, shaft design, and access constraints diverge significantly between minimally invasive and open approaches. Lastly, based on Distribution Channel, market is studied across Direct Sales and Distributors, which delineates commercial pathways that affect pricing transparency, post-sale service levels, and clinical support. Integrating these segmentation lenses provides a coherent framework for targeting clinical evidence generation, commercialization tactics, and operational rollouts that align with stakeholder needs and care delivery realities.

Regional operational intelligence highlighting demand drivers, reimbursement dynamics, regulatory landscapes, and adoption barriers across major global regions

Regional dynamics materially influence the adoption and commercialization of ultrasonic scalpels, driven by differences in regulatory frameworks, reimbursement models, and healthcare infrastructure maturity. In the Americas, clinical decision-making often balances evidence-based performance with cost containment pressures in both public and private systems, creating opportunities for manufacturers that demonstrate clear perioperative benefits and efficient service models. Across Europe, Middle East & Africa, regulatory harmonization efforts and diverse payer landscapes require adaptable market entry strategies and robust local clinical partnerships to navigate heterogeneous procurement practices.

In the Asia-Pacific region, rapid expansion of surgical capacity, investment in minimally invasive surgery training, and ongoing hospital modernization initiatives support demand for advanced energy devices, although procurement cycles and reimbursement arrangements vary significantly between markets. Transitional trends across all regions include increasing emphasis on total cost of care, bundled-payment pilots, and clinician-led adoption pathways that privilege devices with demonstrable impacts on length of stay and readmission risk. Moreover, regional supply chain priorities-such as localization policies, import tariffs, and distribution network robustness-shape how quickly new technologies scale from early adopters to broader clinical practice.

Therefore, regional strategies must align commercialization, evidence generation, and post-sale clinical support to local regulatory and reimbursement realities while maintaining the flexibility to adapt to evolving procurement mandates and clinical training needs.

Competitive and corporate intelligence summarizing leading companies' strategic positioning, technology portfolios, partnership activities, and commercialization approaches

Competitive dynamics in the ultrasonic scalpel space reflect a blend of product innovation, strategic partnerships, and evidence-based positioning. Leading companies differentiate through incremental improvements to energy control, instrument ergonomics, and ancillary consumable ecosystems designed to reduce intraoperative friction. At the same time, collaboration with clinical centers and surgeon champions remains a foundation of commercialization, as peer-reviewed studies and real-world evidence accelerate adoption among broader clinician cohorts.

Beyond product features, companies compete on the strength of their clinical training programs, warranty and service offerings, and the agility of their supply chains. Strategic partnerships with distributors and hospital groups expand market reach, while focused investments in clinical education help overcome initial resistance associated with changing surgical technique. Additionally, intellectual property portfolios and regulatory clearances influence how rapidly new entrants can scale and whether incumbents maintain durable competitive advantages.

Finally, corporate strategies increasingly emphasize outcome-oriented contracts and shared-risk arrangements with health systems, aligning commercial incentives with measurable clinical and operational improvements. These trends suggest that success requires an integrated approach that combines technical excellence with robust clinical engagement and reliable, transparent commercial practices.

Actionable recommendations for industry leaders to accelerate adoption, optimize supply chains, and align clinical and commercial strategies in ultrasonic scalpel markets

Industry leaders can accelerate adoption and strengthen market positioning by aligning product development, clinical engagement, and supply chain resilience with the evolving needs of health systems. First, prioritize investments in clinical evidence generation that demonstrate meaningful improvements in perioperative outcomes, patient recovery, and operational efficiencies. Such evidence should be designed for translation into hospital committee dossiers and payer conversations, thereby reducing adoption friction and supporting procurement approvals.

Second, enhance supply chain transparency and contractual flexibility to address the operational sensitivities that procurement teams now prioritize. This includes offering multi-year service commitments, consignment models, and collaborative inventory planning that mitigate tariff and logistics volatility. Third, tailor commercial approaches to end-user contexts by differentiating strategies for ambulatory surgery centers, hospitals, and specialty clinics; for example, streamline consumable logistics for high-throughput ambulatory settings while emphasizing cross-department utilization in larger hospital systems.

Finally, invest in clinician training and post-sale clinical support to ensure successful integration into both laparoscopic and open surgical workflows. By combining rigorous evidence, resilient operational models, and targeted clinical programs, organizations can convert technological capability into sustainable clinical and commercial value.

Robust research methodology detailing primary and secondary approaches, data validation techniques, expert elicitation, and evidence triangulation employed for analysis

The analytical approach underpinning this report integrates multiple data collection and validation techniques to produce a rigorous, reproducible assessment of device trends and stakeholder priorities. Primary research encompassed structured interviews with surgeons, procurement leaders, and clinical engineers across relevant specialties to capture first-hand insights into device performance, workflow integration challenges, and purchasing criteria. These interviews were complemented by consultations with supply chain and logistics experts to understand sourcing responses to tariff changes and regional trade dynamics.

Secondary research drew on peer-reviewed clinical literature, device regulatory filings, procedural guidelines, and institutional procurement policies to contextualize primary findings. Evidence triangulation techniques ensured that qualitative insights aligned with published clinical outcomes and documented device performance characteristics. Validation steps included cross-referencing interview themes against clinical registries, surgical society guidance, and publicly available hospital procurement frameworks.

Finally, analytical methods applied qualitative coding, thematic synthesis, and scenario analysis to translate raw data into actionable insights. Throughout the process, attention to transparency and reproducibility guided method selection, and analysis emphasized traceability from primary sources to strategic conclusions.

Concluding synthesis that connects technology trends, regulatory pressures, and clinical adoption patterns to inform strategic decision-making for stakeholders

The concluding synthesis ties together technology capabilities, procurement realities, and clinical adoption patterns to offer a coherent basis for strategic decision-making. Ultrasonic scalpels occupy a unique intersection between surgical innovation and operational pragmatism: they promise measurable clinical advantages while requiring careful alignment with hospital workflows, sterilization protocols, and procurement priorities. As a result, successful adoption hinges on credible clinical evidence, robust training programs, and supply chain arrangements that deliver predictable performance.

Regulatory and regional variations will continue to shape the pace and sequence of market uptake, and tariff-related dynamics have underscored the need for resilient sourcing and transparent supplier relationships. Moreover, competitive success will favor organizations that integrate product innovation with outcome-driven commercial models, demonstrating not only device efficacy but also practical value to patients and institutions. In closing, stakeholders should approach ultrasonic scalpel strategy as a multidisciplinary effort that blends clinical validation, operational readiness, and adaptive commercial engagement to achieve sustainable impact across surgical specialties.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ultrasonic Scalpels Market, by Product

  • 8.1. Cavitron Ultrasonic Surgical Aspirator
  • 8.2. Harmonic Scalpel

9. Ultrasonic Scalpels Market, by Mode

  • 9.1. Laparoscopic Surgery
  • 9.2. Open Surgery

10. Ultrasonic Scalpels Market, by Application

  • 10.1. General Surgery
  • 10.2. Gynecology
  • 10.3. Oncology
  • 10.4. Orthopedics
  • 10.5. Urology

11. Ultrasonic Scalpels Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Ultrasonic Scalpels Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors

13. Ultrasonic Scalpels Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ultrasonic Scalpels Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ultrasonic Scalpels Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Ultrasonic Scalpels Market

17. China Ultrasonic Scalpels Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Axon Medical Solutions
  • 18.6. Bioventus Inc.
  • 18.7. BOWA-Electronic GmbH & Co. KG
  • 18.8. Cadence Inc.
  • 18.9. Duomed Belgium
  • 18.10. Elite Medical
  • 18.11. Hangzhou Rex Medical Instrument Co., Ltd.
  • 18.12. Heal Force Bio-Meditech Holdings Limited
  • 18.13. Johnson & Johnson Services, Inc.
  • 18.14. Lepu Medical Technology(Beijing)Co., Ltd.
  • 18.15. LISI Group
  • 18.16. Lotus Surgicals Pvt. Ltd.
  • 18.17. Medtronic PLC
  • 18.18. Olympus Corporation
  • 18.19. Rivolution GmbH
  • 18.20. SHANGHAI LZQ PRECISION TOOL CO., LTD
  • 18.21. Shenzhen Jiayuanda Technology Co.,Ltd.
  • 18.22. Sonics & Materials, Inc.
  • 18.23. Stryker Corporation
  • 18.24. Surgnova Healthcare Technologies
  • 18.25. Soring GmbH
  • 18.26. Wuhan BBT Mini-Invasive Medical Tech. Co., Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ULTRASONIC SCALPELS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ULTRASONIC SCALPELS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ULTRASONIC SCALPELS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ULTRASONIC SCALPELS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY CAVITRON ULTRASONIC SURGICAL ASPIRATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY CAVITRON ULTRASONIC SURGICAL ASPIRATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY CAVITRON ULTRASONIC SURGICAL ASPIRATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY HARMONIC SCALPEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY HARMONIC SCALPEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY HARMONIC SCALPEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS ULTRASONIC SCALPELS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. GCC ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. GCC ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 108. GCC ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. GCC ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GCC ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. G7 ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. G7 ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 126. G7 ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. G7 ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. G7 ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. NATO ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. NATO ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 132. NATO ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NATO ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. NATO ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ULTRASONIC SCALPELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES ULTRASONIC SCALPELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA ULTRASONIC SCALPELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA ULTRASONIC SCALPELS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA ULTRASONIC SCALPELS MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA ULTRASONIC SCALPELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA ULTRASONIC SCALPELS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA ULTRASONIC SCALPELS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)